GAVI hopeful COVID-19 vaccine exports from India can resume in Q3
The Peninsula
ZURICH - The GAVI Vaccine Alliance hopes deliveries of COVID-19 vaccines from India can be resumed in the third quarter of this year, it said on Tuesday, after the pandemic-battered country halted exports to focus on its own surge in infections.
"We remain in regular and close contact with both the government and SII (Serum Institute of India), and remain hopeful that deliveries could resume, in reduced quantity, in the third quarter," GAVI told Reuters. Reuters reported earlier that India is unlikely to resume major exports of COVID-19 vaccines until at least October as it diverts shots for domestic use, a longer-than-expected delay set to worsen supply shortages from the global COVAX initiative which is jointly run by GAVI and the World Health Organization.More Related News